ECLLA is proud to share that our Co-Founder, Jan Rynne, recently joined the Cancer Patients Europe (CPE) Policy Webinar as a panellist to discuss the EU Biotech Act and its potential to improve clinical trials and access to innovative cancer treatments across Europe.
The webinar brought together EU policymakers, clinical research experts, industry leaders and patient advocates to explore how Europe can create a more patient-centred clinical trials framework that improves participation, inclusiveness and equitable access to research.
Representing the CLL patient community, Jan highlighted the importance of ensuring that patients are actively involved in shaping clinical research and policy. Jan also shared her own inspiring experience on clinical trials, demonstrating how access to innovative research can make a profound difference to patients’ lives.
ECLLA is delighted to contribute to these important European policy discussions and thanks Cancer Patients Europe for organising this valuable event.
Join ECLLA and be part of a European community working together to improve care and equity for people living with CLL.